Fujifilm Holdings sees revenue rise but operating profit drops 32% in Q1 of fiscal year ending March 2027, triggering sharp stock decline
Fujifilm Holdings reported its first-quarter results for the fiscal year ending March 2027, with revenue rising 10.3% year-on-year to 826.5 billion yen, a double-digit increase, but operating profit tumbled 32.0% to 51.2 billion yen. The stock plunged 16.6% from the previous day to 3,236 yen. Factors behind the profit decline include higher fixed costs in the healthcare segment's bio CDMO business, one-time expenses related to strengthening the business innovation segment, and the impact of soaring raw material prices. The full-year revenue forecast was raised to 3.56 trillion yen, reflecting strong semiconductor materials sales and currency effects, but the operating profit forecast was left unchanged at 365 billion yen, with first-quarter progress at only around 15%. The market reacted warily to the contrasting figures of an upward revenue revision and an unchanged profit plan, with the price-to-book ratio falling below 1 times to 0.99 times.
LIMO·17dRead more ▾
Fujifilm Holdings announces plan to consider spinning off multifunction printer business
Fujifilm Holdings announced on the 6th that it has begun considering spinning off its subsidiary Fujifilm Business Innovation, which handles office equipment such as multifunction printers, in two to three years. The subsidiary is the largest segment, accounting for about 35 percent of Fujifilm Holdings' total revenue, and aims to list its shares after the separation and independence.
時事通信·20dRead more ▾
Artificial Intelligence▼
Ainex's ENAD Selected by Singapore's National University Hospital After Global Competition
Ainex Corporation has signed an agreement to supply its AI-assisted endoscopy diagnostic software ENAD to Singapore's National University Hospital, marking the solution's first adoption by a leading public tertiary hospital in the city-state. ENAD, Korea's first and only AI-assisted solution approved for both upper and lower gastrointestinal endoscopy, was chosen after evaluation alongside competing solutions from Medtronic, Olympus, and Fujifilm. The agreement, which follows ENAD's regulatory approval from Singapore's Health Sciences Authority in April 2025, also includes expanded joint clinical research to further enhance the platform's diagnostic performance. Ainex plans to collect additional real-world data to improve detection of adenomas, neoplasms, sessile serrated lesions, early gastric cancer, and to develop algorithms for intestinal metaplasia and inflammatory bowel disease. The deployment at National University Hospital is expected to serve as a springboard for Ainex's broader international expansion.
PR Newswire·23dRead more ▾
Robotics & Physical AI▲
Robotic Endoscopy Devices Market to Reach $6.5 Billion by 2034
The global robotic endoscopy devices market is projected to grow from $2.8 billion in 2025 to $6.5 billion by 2034, at a compound annual growth rate of approximately 10%, according to a report by DelveInsight. North America accounted for about 42% of global revenue in 2025, driven by widespread adoption of robotic-assisted surgical technologies and the presence of major players such as Intuitive Surgical, Medtronic, and Johnson & Johnson MedTech. The therapeutic robotic endoscopes category was the largest product segment, while the Asia-Pacific region is expected to see the highest growth due to aging populations and rising investments in robotic surgery. Key companies in the market include Intuitive Surgical, Johnson & Johnson MedTech, Medtronic, Olympus, Boston Scientific, FUJIFILM, Stryker, KARL STORZ, Asensus Surgical, and CMR Surgical. Recent developments include FDA clearance of Medtronic's Hugo system for urologic procedures in December 2025 and FDA 510(k) clearance of CMR Surgical's Versius Plus system for cholecystectomy.
GlobeNewswire·35dRead more ▾
Artificial Intelligence▲impact 4
Nvidia Expands AI Push Across Japan's Largest Industries
Nvidia is widening its reach across Japan's largest industries. During a visit to Tokyo, CEO Jensen Huang announced partnerships covering robotics, health care, banking, manufacturing, automobiles, quantum computing and gaming. Japanese companies including FANUC, Sony, Hitachi, Kubota and SoftBank plan to work with Nvidia on physical AI models for robots and industrial systems. In health care, several drugmakers are using Nvidia's BioNeMo platform for drug discovery, while Canon and Fujifilm introduced medical imaging systems built with Nvidia technology. Toyota is expanding its work with Nvidia on driver-assistance software, factory simulations and traffic systems, Mizuho and Sumitomo Mitsui are building AI infrastructure for banking, and RIKEN is preparing Blackwell-powered supercomputers for scientific and quantum research.
GuruFocus·41dRead more ▾
Artificial Intelligence▲impact 4
Nvidia CEO Huang unveils broad AI partnerships across Japan's key industries
Nvidia CEO Jensen Huang unveiled a broad slate of AI products, partnerships, and customer deployments at the company's Japan AI event in Tokyo on July 15. The announcements spanned physical AI, healthcare, financial services, quantum computing, automotive, manufacturing, and gaming, highlighting Nvidia's push to position its technologies at the forefront of Japan's next-generation AI infrastructure. In physical AI and robotics, Nvidia launched Cosmos 3 Edge for on-device vision reasoning, and companies including FANUC, Fujitsu, Hitachi, Kawasaki Heavy Industries, Kubota, NEC, SoftBank, Sony Group, and Yaskawa Electric plan to join the Nvidia Cosmos Coalition to develop open physical AI models. In healthcare, Astellas Pharma, Eisai, Daiichi Sankyo, Ono Pharmaceutical, and Takeda Pharmaceutical are deploying Nvidia BioNeMo for AI-powered drug discovery, while Canon and Fujifilm introduced Nvidia-powered next-generation CT systems, and Kawasaki Heavy Industries is advancing AI-enabled surgical and hospital robots. In financial services, Mizuho Financial plans Japan's largest on-premises AI factory for banking, Sumitomo Mitsui Financial has deployed an AI factory through Japan Research Institute, and Rakuten Bank is developing AI transaction foundation models using Nvidia Agent Toolkit. Huang emphasized that the next wave of AI will be physical AI—robots, factories, vehicles, and industrial systems that can perceive, reason, and act in the real world—and said Japan's leadership in robotics, manufacturing, and precision engineering positions it to play a leading role in this transition.
Seeking Alpha·42dRead more ▾
4901.JP▲
Fujifilm's 'Utsurundesu' disposable camera sees resurgence in popularity 40 years after launch
Fujifilm's lens-fitted film camera 'Utsurundesu' marks its 40th anniversary, with the analog photography experience regaining popularity, especially among young people. The first model was released on July 1, 1986, priced at 1,380 yen, and cumulative sales have exceeded 1.7 billion units. Sales peaked around 1997 but declined with the spread of digital cameras and mobile phones. However, popularity has resurged since the late 2010s. At Don Quijote stores, sales have been climbing since the pandemic, and Loft experienced temporary stock shortages. Starting in August, Fujifilm will launch its first new products in 20 years: a waterproof model priced around 4,480 yen and a black-and-white film model priced around 4,300 yen.
時事通信·45dRead more ▾